China Animal Vaccine Industry Report, 2009-2010
-
Jun.2010
- Hard Copy
- USD
$1,400
-
- Pages:65
- Single User License
(PDF Unprintable)
- USD
$1,500
-
- Code:
ZYM007
- Enterprise-wide License
(PDF Printable & Editable)
- USD
$2,250
-
- Hard Copy + Single User License
- USD
$1,600
-
China’s animal vaccine market has grown up steadily despite all the twists and turns in the livestock and poultry breeding market over the past four years. In 2009, the market scale reached around RMB6.2 billion, up 14.8% year-on-year, and will keep expanding with the development of the livestock and poultry breeding market.
China’s Animal Vaccine Market Scale and Y-o-Y Growth, 2006-2009 (Unit: RMB bn)
Source: ResearchInChina
Restricted by people’s living habits and economic conditions, animal vaccine R&D and production in China mainly focuses on economic animal vaccines. In the meantime, the development of traditional national compulsory vaccines such as foot and mouth disease vaccine, bird flu vaccine, blue ear disease vaccine, hog cholera vaccine in China are relatively mature as a result of national animal vaccine procurement policies. In 2009, the compulsory vaccines accounted for over 86% shares in the entire animal vaccine market, which was basically shared by domestic companies. China Animal Husbandry Industry Co., Ltd. (CAHIC), Yebio Bioengineering Co., Ltd. (Yebio QD), Inner Mongolia Jinyu Group Co., Ltd. (Jinyu Group), Harbin Pharmaceutical Group Bio-vaccine Co., Ltd. (formerly “The First Bio-product Manufactory of Heilongjiang Province”) and Xinjiang Tecon Animal Husbandry Bio-technology Co., Ltd. (Tecon) accounted for 40.7% shares. However, commercial animal vaccines, pet vaccines in particular, had a higher dependence on import. Imported pet vaccines approximately accounted for 70% of total domestic market sales value, and 30% of total domestic market sales volume.
Market Shares of China’s Key Animal Vaccine Manufacturers by Sales, 2009
Source: ResearchInChina
Besides the operating environment, development status, market scale, supply & demand, competition, import & export and development prospect of China’s animal vaccine industry, the report also made an in-depth analysis of the development, market scale, and development trend of global animal vaccine industry, as well as the operation, development prospect and advantages of China’s key animal vaccine manufacturers.
1. Animal Vaccine Overview
1.1 Definition & Classification of Animal Vaccines
1.2 Definition & Classification of Animal Biological Products
2. Animal Vaccine Industry Operating Environment
2.1 Macro Environment
2.2 Policy Environment
2.3 Social Environment
3. Global Animal Vaccine Industry
3.1 Overview
3.2 Market Scale
3.3 Key Countries and Regions
3.3.1 USA
3.3.2 Europe
3.4 Development Prospect
4. China’s Animal Vaccine Industry
4.1 Overview
4.2 Market Scale
4.3 Supply & Demand
4.4 Competition
4.5 Import & Export
4.5.1 Export
4.5.2 Import
4.6 Development Prospect
5. Animal Vaccine Market Segments in China
5.1 Swine Vaccines
5.2 Poultry Vaccines
5.3 Cattle & Sheep Vaccines
5.4 Pet Vaccines
6. Key Manufacturers
6.1 CAHIC
6.1.1 Company Profile
6.1.2 Operation
6.1.3 Animal Vaccine Business
6.1.4 Animal Vaccine Business Development Prospect & Advantages
6.2 Jinyu Group
6.2.1 Company Profile
6.2.2 Operation
6.2.3 Animal Vaccine Business
6.2.4 Animal Vaccine Business Development Prospect & Advantages
6.3 Tecon
6.3.1 Company Profile
6.3.2 Operation
6.3.3 Animal Vaccine Business
6.3.4 Animal Vaccine Business Development Prospect
6.4 Ningbo Tech-Bank
6.4.1 Company Profile
6.4.2 Operation
6.4.3 Chengdu Tech-Bank (formerly Chengdu Jinghua)
6.5 Shenghua Biok
6.5.1 Company Profile
6.5.2 Operation
6.5.3 Yebio QD
6.6 Huasun Group
6.6.1 Company Profile
6.6.2 Operation
6.6.3 Sichuan Huasun
6.7Harbin Pharmaceutical Group
6.7.1 Company Profile
6.7.2 Animal Vaccine Business Status Quo & Prospect
6.8 Foreign Manufacturers in China
6.8.1 Merial
6.8.2 Boehringer-Ingelheim
6.8.3 Bayer
6.8.4 Novartis
Animal Vaccine Types and Characteristics
China’s GDP Growth Margin Changes, 2007-2010Q1
China’s Meat, Poultry & Egg and Milk Output, 2007-2009
World’s Animal Vaccine Output Value Distribution, 2008
World’s Animal Vaccine Market Structure by Animal Species, 2009
World’s Animal Vaccine Market Scale, 2004, 2008 & 2009
U.S. Animal Vaccine Product Structure by Animal Species, 2009
U.S. Main Animal Vaccines Output, 2008
U.S. Various Animal Vaccines Y-o-Y Changes, 2008
U.S. Main Animal Vaccine Product Types, 2008
European Animal Vaccine Product Structure, 2009
China’s Animal Vaccine Market Share by Category, 2009
China’s Animal Vaccine Industry Market Scale & Growth, 2006-2009
China’s Key Animal Vaccine Manufacturers
Production of China’s Key Animal Vaccine Manufacturers
China’s Animal Vaccine Consumption Structure by Animal Species, 2009
China’s Animal Vaccination Program, 2010
Market Shares of China’s Main Animal Vaccine Manufacturers by Sales, 2009
Quantity of Manufacturers of Key Leading Companies in Government Animal Vaccine Procurement, 2009
China’s Animal Vaccine Export Volume, Value and Average Unit Price, 2007-2009
China’s Animal Vaccine Oversea Market Distribution, 2009
China’s Animal Vaccine Import Volume, Value and Average Unit Price, 2007-2009
Origins of China’s Imported Animal Vaccines, 2009
China’s Animal Vaccine Industry Development Driving Forces
China’s Animal Vaccine Market Scale, 2010
China’s Pig Inventory and Slaughter Quantity, 2000-2009
China’s Pig Vaccine Market Scale, 2008-2009
Performance Comparison of China’s Various Hog Cholera Vaccines
China’s Poultry Vaccine Market Scale, 2008-2009
Ratio of China’s Poultry Vaccine by Category, 2009
Cattle & Sheep Vaccine Market Scale, 2008-2009
Foot and Mouth Disease in China, 2009
China’s Pet Vaccine Market Scale, 2008-2010
China’s Pet Vaccine Suppliers
CAHIC Operating Income and Net Income, 2007-2010Q1
CAHIC Operating Profit Margin Change, 2007-2009
CAHIC Operating Income & Structure, 2007-2009
CAHIC Operating Income by Region, 2009
CAHIC Animal Vaccine Output Capacity Distribution
CAHIC Animal Vaccine Sales Ratio by Category, 2007-2009
CAHIC Compulsory Vaccine and Market- oriented Vaccine Ratios, 2009
CAHIC Compulsory Vaccine Ratio by Category, 2009
CAHIC Animal Vaccine Gross Profit, 2007-2009
Jinyu Group Operating Income and Net Income, 2007-2010Q1
Jinyu Group Operating Income & Structure, 2007-2009
Jinyu Group Operating Profit Margin Change, 2007-2009
Jinyu Group Operating Income by Region, 2009
Jinyu Group Animal Vaccine Output Capacity Distribution
Jinyu Group Operating Income and Gross Profit Margin Change, 2007-2009
Tecon Operating Income and Net Income, 2007-2010Q1
Tecon Operating Income and Structure, 2007-2009
Tecon Operating Profit Margin Change, 2007-2009
Ratio of Tecon R&D Input to Operating Income, 2007-2009
Tecon Operating Income by Region, 2009
Tecon Animal Vaccine Income and Gross Profit Margin Changes, 2007-2009
Ningbo Tech-Bank Operating Income and Net Income, 2008-2010Q1
Ningbo Tech-Bank Operating Income and Structure, 2008-2009
Ningbo Tech-Bank Main Product Gross Profit Margin Changes, 2008-2009
Chengdu Tech-Bank Animal Vaccine Income Structure, 2009
Shenghua Biok Operating Income and Net Income, 2007-2009
Shenghua Biok Main Business Revenue and Structure, 2007-2009
Shenghua Biok Operating Margin Change, 2007-2009
Yebio QD Operating Income and Net Income, 2008-2009
Huasun Group Operating Income and Net Income, 2007-2009
Huasun Group Operating Income and Structure, 2008-2009
Huasun Group Gross Profit Margin Change, 2007-2009
China Contract Research Organization (CRO) Industry Report, 2020-2026
The contract research organization (CRO) industry has been galloping amid the global pharmaceutical market steadily in head way, the vibrant financing in the medical and health sector, and the prolife...
China Human Vaccine Industry Report, 2020-2026
In China, the lot release for human vaccines plunged by 17.7% in 2018 when the production record fraud of rabies vaccines for human use, freeze-dried by Changsheng Bio-Technology was exposed. The impa...
China Pharmaceutical Distribution Industry Report, 2019-2026
The Chinese pharmaceutical distribution market has been expanding steadily over the recent years, being valued at RMB2,330.3 billion in 2019 with a year-on-year increase of 8.9%, of which the pharmace...
China Pharmaceutical Distribution Industry Report, 2019-2025
China’s pharmaceutical distribution industry has sustained steady growth over the years. In 2018, the market was worth RMB2,194.5 billion, a 9.6% rise from RMB2,001.6 billion (up by 8.4% YoY) in 2017,...
China Pharmaceutical Packaging Industry Report, 2019-2025
Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018...
China Blood Product Industry Report, 2018-2022
The blood product industry in China develops under stimulation of industry policies and downstream demand. The country recorded total lot release volume of 64.11 million bottles of blood products in 2...
China Pharmaceutical Distribution Industry Report, 2017-2021
The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit...
China Blood Product Industry Report, 2017-2021
China’s blood product market size mushroomed in 2016 under the impetus of liberalization of limited-price policy, price rises in varying degrees and lot release volume growth for blood products in 201...
China Pharmaceutical Packaging Industry Report, 2016-2021
Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, ...
China Pharmaceutical Glass Packaging Industry Report, 2014-2017
In recent years, advances in new healthcare reform have boosted market demand from China pharmaceuticals industryand driven growth in the demand from pharmaceutical packaging industry. In 2014, the Ch...
China Vitamin Industry Report,2014-2017
China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...
China Chemical Pharmaceutical Industry Report, 2013-2016
Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...
China Pharmaceutical Distribution Industry Report, 2013
Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...
China Pharmaceutical Glass Packaging Industry Report, 2013-2016
Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...
China Chinese Patent Medicine Industry Report, 2013-2016
Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...
Global and China Insulin Industry Report, 2013-2017
As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...
China Large Volume Parenteral (LVP) Industry Report, 2013-2015
Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...
China Vitamin Industry Report, 2012-2015
As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...